# Iasibon · 1 mg/ml · Koncentrat do sporządzania roztworu do infuzji · amp. 2 1 ml



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `89227`
- **eu-number** — `EU/1/10/659/003`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Pharmathen S.A.

## Proof

Record pl:presentation:89227 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Iasibon 1 mg](https://dosidal.ai/pack/be/387536-01) — BE — same product (EU central number)
- [IASIBON](https://dosidal.ai/pack/cz/0167978) — CZ — same product (EU central number)
- [Iasibon](https://dosidal.ai/pack/eu/EU-1-10-659-003) — EU — same product (EU central number)
- [IASIBON 1 MG KONCENTRÁTUM OLDATOS INFÚZIÓHOZ](https://dosidal.ai/pack/hu/210787648) — HU — same product (EU central number)
- [Iasibon 1 mg concentrate for solution for infusion](https://dosidal.ai/pack/ie/EU-1-10-659-003) — IE — same product (EU central number)
- [Iasibon 1 mg infúzny koncentrát](https://dosidal.ai/pack/sk/05852) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
